Cargando…
Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils
Semen harbors amyloid fibrils formed by proteolytic fragments of prostatic acid phosphatase (PAP248-286 and PAP85-120) and semenogelins (SEM1 and SEM2) that potently enhance HIV infectivity. Amyloid but not soluble forms of these peptides enhance HIV infection. Thus, agents that remodel these amyloi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582112/ https://www.ncbi.nlm.nih.gov/pubmed/26319581 http://dx.doi.org/10.1242/bio.010215 |
_version_ | 1782391651854974976 |
---|---|
author | Castellano, Laura M. Hammond, Rebecca M. Holmes, Veronica M. Weissman, Drew Shorter, James |
author_facet | Castellano, Laura M. Hammond, Rebecca M. Holmes, Veronica M. Weissman, Drew Shorter, James |
author_sort | Castellano, Laura M. |
collection | PubMed |
description | Semen harbors amyloid fibrils formed by proteolytic fragments of prostatic acid phosphatase (PAP248-286 and PAP85-120) and semenogelins (SEM1 and SEM2) that potently enhance HIV infectivity. Amyloid but not soluble forms of these peptides enhance HIV infection. Thus, agents that remodel these amyloid fibrils could prevent HIV transmission. Here, we confirm that the green tea polyphenol, epigallocatechin-3-gallate (EGCG), slowly remodels fibrils formed by PAP248-286 termed SEVI (semen derived enhancer of viral infection) and also exerts a direct anti-viral effect. We elucidate for the first time that EGCG remodels PAP85-120, SEM1(45-107), and SEM2(49-107) fibrils more rapidly than SEVI fibrils. We establish EGCG as the first small molecule that can remodel all four classes of seminal amyloid. The combined anti-amyloid and anti-viral properties of EGCG could have utility in preventing HIV transmission. |
format | Online Article Text |
id | pubmed-4582112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The Company of Biologists |
record_format | MEDLINE/PubMed |
spelling | pubmed-45821122015-10-02 Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils Castellano, Laura M. Hammond, Rebecca M. Holmes, Veronica M. Weissman, Drew Shorter, James Biol Open Research Article Semen harbors amyloid fibrils formed by proteolytic fragments of prostatic acid phosphatase (PAP248-286 and PAP85-120) and semenogelins (SEM1 and SEM2) that potently enhance HIV infectivity. Amyloid but not soluble forms of these peptides enhance HIV infection. Thus, agents that remodel these amyloid fibrils could prevent HIV transmission. Here, we confirm that the green tea polyphenol, epigallocatechin-3-gallate (EGCG), slowly remodels fibrils formed by PAP248-286 termed SEVI (semen derived enhancer of viral infection) and also exerts a direct anti-viral effect. We elucidate for the first time that EGCG remodels PAP85-120, SEM1(45-107), and SEM2(49-107) fibrils more rapidly than SEVI fibrils. We establish EGCG as the first small molecule that can remodel all four classes of seminal amyloid. The combined anti-amyloid and anti-viral properties of EGCG could have utility in preventing HIV transmission. The Company of Biologists 2015-08-28 /pmc/articles/PMC4582112/ /pubmed/26319581 http://dx.doi.org/10.1242/bio.010215 Text en © 2015. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Research Article Castellano, Laura M. Hammond, Rebecca M. Holmes, Veronica M. Weissman, Drew Shorter, James Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils |
title | Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils |
title_full | Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils |
title_fullStr | Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils |
title_full_unstemmed | Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils |
title_short | Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils |
title_sort | epigallocatechin-3-gallate rapidly remodels pap85-120, sem1(45-107), and sem2(49-107) seminal amyloid fibrils |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582112/ https://www.ncbi.nlm.nih.gov/pubmed/26319581 http://dx.doi.org/10.1242/bio.010215 |
work_keys_str_mv | AT castellanolauram epigallocatechin3gallaterapidlyremodelspap85120sem145107andsem249107seminalamyloidfibrils AT hammondrebeccam epigallocatechin3gallaterapidlyremodelspap85120sem145107andsem249107seminalamyloidfibrils AT holmesveronicam epigallocatechin3gallaterapidlyremodelspap85120sem145107andsem249107seminalamyloidfibrils AT weissmandrew epigallocatechin3gallaterapidlyremodelspap85120sem145107andsem249107seminalamyloidfibrils AT shorterjames epigallocatechin3gallaterapidlyremodelspap85120sem145107andsem249107seminalamyloidfibrils |